Page last updated: 2024-12-09

2-(4-formylphenoxy)acetic acid [2-(4-methylanilino)-4-thiazolyl]methyl ester

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

You're describing a molecule with a complex structure, and while it's unlikely to have a common name, it's definitely a molecule that could be relevant to research. Let's break down its components and discuss potential reasons for its importance:

**Structure Breakdown:**

* **2-(4-formylphenoxy)acetic acid:** This is a substituted acetic acid. It features a benzene ring (phenoxy) with a formyl group (CHO) at the para position (4-position) and an acetic acid group attached to the second position.
* **[2-(4-methylanilino)-4-thiazolyl]methyl ester:** This part is a thiazole ring (5-membered ring with nitrogen and sulfur) substituted with a 4-methylanilino group (a benzene ring with an amino group and a methyl group). It's attached as a methyl ester to the acetic acid group.

**Potential Research Significance:**

Here are some reasons why this molecule could be of interest to researchers:

* **Pharmacological Activity:** This compound combines structural features that are commonly found in pharmaceuticals. The thiazole ring and the aniline group are often present in antibacterial, antifungal, and anti-inflammatory agents. The formyl group can be important for interacting with enzymes or receptors.
* **Probing Biological Systems:** It could be used as a tool to investigate the activity of specific enzymes or proteins. By modifying the formyl group or other parts of the molecule, researchers could create a series of compounds with varying affinities and use them to map out binding sites or study their effect on specific biological processes.
* **Material Science:** The presence of aromatic rings and reactive groups could make it interesting for developing new materials, particularly polymers or composites. It might be used for synthesizing new polymers with specific properties, or for attaching this molecule to existing materials to modify their surface properties.

**Finding More Information:**

To learn more about this specific compound, you would need to:

1. **Search Chemical Databases:** Use databases like PubChem, SciFinder, or Reaxys to search for this exact structure or potentially related structures. You might find information on its synthesis, properties, or biological activity if it has been studied.
2. **Look for Publications:** Research academic journals and databases for publications that mention this specific compound or similar structures. You could find research papers investigating its synthesis, biological activity, or potential applications.

**Disclaimer:** Without more information about the research context, it's impossible to pinpoint the exact reason for this molecule's importance. It's always best to consult with a chemist or researcher in the relevant field for specific insights.

Cross-References

ID SourceID
PubMed CID2127949
CHEMBL ID1477262
CHEBI ID109365

Synonyms (15)

Synonym
smr000253731
MLS000336177
CHEBI:109365
[2-(4-methylanilino)-1,3-thiazol-4-yl]methyl 2-(4-formylphenoxy)acetate
HMS2522F21
CHEMBL1477262
SR-01000054588-1
sr-01000054588
2-(4-formylphenoxy)acetic acid [2-(4-methylanilino)-4-thiazolyl]methyl ester
Q27188475
AKOS030686978
Z25126098
756845-94-0
{2-[(4-methylphenyl)amino]-1,3-thiazol-4-yl}methyl 2-(4-formylphenoxy)acetate
EN300-1188996
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency39.81070.631035.7641100.0000AID504339
Chain A, Ferritin light chainEquus caballus (horse)Potency50.11875.623417.292931.6228AID485281
LuciferasePhotinus pyralis (common eastern firefly)Potency2.68550.007215.758889.3584AID588342
thioredoxin reductaseRattus norvegicus (Norway rat)Potency0.14130.100020.879379.4328AID588453
BRCA1Homo sapiens (human)Potency10.00000.89137.722525.1189AID624202
ATAD5 protein, partialHomo sapiens (human)Potency20.73290.004110.890331.5287AID504466; AID504467
Microtubule-associated protein tauHomo sapiens (human)Potency17.78280.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
P53Homo sapiens (human)Potency56.23410.07319.685831.6228AID504706
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency2.51190.01262.451825.0177AID485313
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency6.51310.00419.984825.9290AID504444
importin subunit beta-1 isoform 1Homo sapiens (human)Potency63.09575.804836.130665.1308AID540263
DNA polymerase betaHomo sapiens (human)Potency89.12510.022421.010289.1251AID485314
ras-related protein Rab-9AHomo sapiens (human)Potency2.81840.00022.621531.4954AID485297
snurportin-1Homo sapiens (human)Potency63.09575.804836.130665.1308AID540263
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency60.11980.425612.059128.1838AID504891
survival motor neuron protein isoform dHomo sapiens (human)Potency35.48130.125912.234435.4813AID1458
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]